About this trial
Digital interventions have the potential to support healthier behaviors among pregnant and postpartum women (PPW) with substance use disorders (SUDs) and may also provide a promising method for reducing their self-stigma. Enhearten is a digital intervention designed to foster adherence to medications for addiction treatment (MAT) while considering the unique needs of PPW, but its effects on self-stigma, treatment retention, and SUD outcomes have not been rigorously tested. The investigators will conduct an individual-level multicenter randomized controlled trial to test the feasibility, acceptability, and efficacy of Enhearten on reducing self-stigma and on improving SUD treatment and recovery outcomes with a stigma-focused ecological momentary intervention (EMI) designed to: 1) screen for feelings of stigma and 2) counteract these vulnerabilities among PPW with SUD via just-in-time interventions.
Eligibility criteria
Qualifiers
Pregnant women and new mothers (up to 12 months postpartum)
Adult (≥18 years of age)
Fluent in English
Currently owns or has ready (daily) access to a smartphone or tablet to use Enhearten.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Enhearten with EMI
- Waitlist Control Group
Treatment groups
Sponsors and collaborators
Washington University School of Medicine
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator